Eisai Competitors and Similar CompaniesClear all
Nipro's competitors and similar companies include Agios Pharmaceuticals and Pharmstandard.
 Nipro Nipro Corporation (ニプロ株式会社) is a company that has expertise in medical devices, pharmaceuticals, pharma packaging, and regenerative medicine business. |  Agios Pharmaceuticals Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism. |  Pharmstandard Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products. | |
Founding Date | Founding Date 1954 | Founding Date 2008 | Founding Date 2003 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Cambridge, US HQ | Locations Dolgoprudny, RU HQ Kursk, RU Moscow, RU Petrovo Dalnee, RU Tomsk, RU Ufa, RU Vol'ginskii, RU | |
Employees | Employees 38,117 | Employees 53611% increase | Employees 1,77814% increase |
Valuation ($) | Valuation ($) 1.5 b | Valuation ($) 2.7 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) ¥660.5b (FY, 2026) | Revenue (est.) $54m (FY, 2025) | Revenue (est.) ₽152.1b (FY, 2024) |
Cost of goods | Cost of goods ¥388.5b (FY, 2026) | Cost of goods $6.3m (FY, 2025) | Cost of goods ₽117b (FY, 2024) |
Gross profit | Gross profit ¥272b (FY, 2026) | Gross profit $47.7m (FY, 2025) | Gross profit ₽35.2b (FY, 2024) |
Net income | Net income ¥15.7b (FY, 2026) | Net income ($412.8m) (FY, 2025) | Net income ₽22.7b (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Agios Pharmaceuticals
HQ
Cambridge, US
Employees
536↑ 11% increase
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
View companyPharmstandard
HQ
Dolgoprudny, RU
Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.
View company